Chubb Limited (CB)
(Delayed Data from NYSE)
$293.10 USD
+5.70 (1.98%)
Updated Oct 16, 2024 04:00 PM ET
After-Market: $293.18 +0.08 (0.03%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth B Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$293.10 USD
+5.70 (1.98%)
Updated Oct 16, 2024 04:00 PM ET
After-Market: $293.18 +0.08 (0.03%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth B Momentum C VGM
Zacks News
What's in Store for Alliance Data (ADS) in Q2 Earnings?
by Zacks Equity Research
Alliance Data's (ADS) in Q2 earnings is likely to be impacted by improved performance at Card Service segment, though high expenses might weigh on operating margins.
Factors Likely to Influence Progressive's (PGR) Q2 Earnings
by Zacks Equity Research
Progressive's (PGR) second quarter earnings likely have been benefited from solid policies in force and competitive rates.
7 Insurers Poised for Q2 Outperformance on Multiple Tailwinds
by Tanuka De
We have identified seven insurers poised to outshine in the second quarter banking on solid fundamentals and favorable macro environment.
Why Chubb (CB) Could Beat Earnings Estimates Again
by Zacks Equity Research
Chubb (CB) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Allstate (ALL) Expects to Incur Catastrophe Loss in May
by Zacks Equity Research
Being a relatively large property insurance business, Allstate (ALL) is significantly exposed to catastrophic events
Chubb or Travelers: Which P&C Insurer is Better Placed?
by Tanuka De
Given a favorable operating backdrop, let's see which stock - Chubb (CB) or Travelers (TRV) is a more viable investment option based on comparative analysis.
Chubb Rallies 15% Year to Date: What's Aiding the Stock?
by Zacks Equity Research
Chubb's (CB) operational excellence and growth initiatives help the stock continue the bull run.
W.R. Berkley Board Okays Dividend Hike and Special Dividend
by Zacks Equity Research
W.R. Berkley's (WRB) recent dividend hike and special dividend reflects operational excellence and effective capital deployment.
Chubb (CB) Up 1.2% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Chubb (CB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Unum (UNM) Board Approves Dividend Hike & Share Buyback
by Zacks Equity Research
Unum's (UNM) efforts to increase dividend and approve share buyback program reflect its operational strength supporting effective capital deployment.
The Zacks Analyst Blog Highlights: Chubb, Las Vegas Sands, Biogen, Dollar General and Canadian Pacific
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Chubb, Las Vegas Sands, Biogen, Dollar General and Canadian Pacific
Top Research Reports for Chubb, Las Vegas Sands & Biogen
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Chubb (CB), Las Vegas Sands (LVS) and Biogen (BIIB).
Allstate (ALL) Expects to Incur Catastrophe Loss for April
by Zacks Equity Research
Allstate (ALL) expects to incur $290 million pre-tax catastrophe loss for April, which can be attributed to seven weather-related events.
Chubb (CB) Q1 Earnings Top Estimates, Premiums Rise Y/Y
by Zacks Equity Research
Chubb (CB) Q1 reflects solid premium growth and net investment income as well as lower cat loss.
Chubb (CB) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Chubb (CB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Is Chubb (CB) Up 2.6% Since Last Earnings Report?
by Zacks Equity Research
Chubb (CB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Horace Mann (HMN) Rewards Shareholders With 1% Dividend Hike
by Zacks Equity Research
Horace Mann's (HMN) 1% dividend hike to add shareholder value will buoy investors' optimism on the stock.
Chubb to Propose 2.7% Dividend Hike, Share More Profits
by Zacks Equity Research
Chubb's (CB) intention to hike 2.7% dividend testifies solid operational performance supporting capital deployment initiatives.
Fidelity National (FNF) Q4 Earnings Lag Estimates & Down Y/Y
by Zacks Equity Research
Fidelity National's (FNF) fourth-quarter earnings suffer due to diminishing revenues.
Q4 Earnings Drive Insurance ETFs Higher
by Sweta Killa
The Q4 earnings of insurance industry players had a positive impact on the related ETFs that saw smooth trading over the past month.
Lincoln National (LNC) Beats on Q4 Earnings, Revenues Miss
by Zacks Equity Research
Lincoln National (LNC) Q4 results reflect increase in revenues and a very low rise in expense.
The Zacks Analyst Blog Highlights: Procter & Gamble, Becton, Dickinson, Dominion, Chubb and Estee Lauder
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Procter & Gamble, Becton, Dickinson, Dominion, Chubb and Estee Lauder
MetLife (MET) Q4 Earnings Beat Estimates, Revenues Miss
by Zacks Equity Research
MetLife's (MET) Q4 earnings gain from a decline in total expenses and revenues remain flat year over year.
Chubb (CB) Q4 Earnings Beat Estimates, Premiums Improve
by Zacks Equity Research
Premium revenue growth, record investment performance and better commercial P&C pricing boost Chubb's (CB) Q4 results.
Allstate (ALL) Q4 Earnings & Revenues Beat Estimates
by Zacks Equity Research
Allstate (ALL) Q4 earnings beat on better-than-expected revenues, despite catastrophe losses.